As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Genworth Financial

  • Thursday's Range: $2.45-$2.75
  • 52-Week Range: $2.20-$9.19
  • Thursday's Volume: 5.2 million
  • Three-Month Average Volume: 9.36 million

Genworth Financial  (GNW - Get Report)  provides insurance, retirement and homeownership solutions in the U.S. and internationally. This stock is trading up 9.2% to $2.71 in Thursday's trading session.

From a technical perspective, Genworth Financial is ripping sharply higher here back above its 20-day moving average of $2.56 a share with decent upside volume flows. This spike to the upside is now quickly pushing shares of Genworth Financial within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $2.75 to $2.86 a share with high volume.

Traders should now look for long-biased trades in Genworth Financial as long as it's trending above some near-terms support at $2.39 or above its new 52-week low of $2.20 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 9.36 million shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $3.25 to $3.50, or even its 50-day moving average of $3.51, or even $4 a share.

Trillium Therapeutics

  • Thursday's Range: $8.03-$8.79
  • 52-Week Range: $7.16-$29.92
  • Thursday's Volume: 20,000
  • Three-Month Average Volume: 63,737

Trillium Therapeutics  (TRIL) , an immuno-oncology company, develops therapies for the treatment of cancer. This stock is trading up 4.4% to $8.55 in Thursday's trading session.

From a technical perspective, Trillium Therapeutics is spiking notably higher here right above some near-term support at $7.50 a share with lighter-than-average volume. This stock has been attempting to carve out a double bottom chart pattern over the last few weeks, with shares finding some buying interest at $7.16 to $7.50 a share. Shares of Trillium Therapeutics are now starting to spike higher above those support levels, and it's beginning to trend within range of triggering a big breakout trade. That trade will trigger if this stock manages to clear its 20-day moving average of $8.82 a share and then once it takes out some key near-term overhead resistance levels at $9.21 to $9.61 a share with high volume.

Traders should now look for long-biased trades in Trillium Therapeutics as long as it's trending above some key near-term support levels at $7.50 or above its new 52-week low of $7.16 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 63,737 shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at around $11 to its 50-day moving average of $11.42 a share.

Genesis Healthcare

  • Thursday's Range: $1.81-$1.92
  • 52-Week Range: $1.55-$9.18
  • Thursday's Volume: 78,000
  • Three-Month Average Volume: 302,061

Genesis Healthcare  (GEN - Get Report) , together with its subsidiaries, provides post-acute care services through a network of skilled nursing centers and assisted/senior living communities in the U.S. This stock is trading up 2.7% to $1.87 in Thursday's trading session.

From a technical perspective, Genesis Healthcare is trending notably higher here right above some near-term support at $1.75 a share with lighter-than-average volume. This stock has been uptrending a bit over the last few weeks, with shares moving higher off its new 52-week low of $1.55 to its recent high of $1.94 a share. During that uptrend, shares of Genesis Healthcare have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed this stock within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $1.94 to $2.03 a share with high volume.

Traders should now look for long-biased trades in Genesis Healthcare as long as it's trending above some near-term support at $1.75 or above its new 52-week low of $1.55 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 302,061 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 20-day moving average of $2.43 to $2.75, or even $3 a share.

Tronox

  • Thursday's Range: $3.35-$3.86
  • 52-Week Range: $2.79-$23.06
  • Thursday's Volume: 602,000
  • Three-Month Average Volume: 1.29 million

Tronox  (TROX - Get Report)  produces and markets titanium-bearing mineral sands and titanium dioxide pigment in North America, Europe, South Africa and the Asia-Pacific region. This stock is trading up 6.8% to $3.63 in Thursday's trading session.

From a technical perspective, Tronox is trending sharply higher here back above its 20-day moving average of $3.50 a share with decent upside volume flows. This stock has been attempting to carve out a major bottoming chart pattern over the last two months, with shares finding some buying interest numerous times when it dips to around or just under $3 a share. Shares of Tronox are now ripping higher off those support levels, and it's quickly moving within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out its 50-day moving average of $4.10 a share and then once it clears some more key resistance levels at $4.12 to $4.13 a share with high volume.

Traders should now look for long-biased trades in Tronox as long as it's trending above Thursday's intraday low of $3.35 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.29 million shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $4.83 to $5, or even $5.50 a share.

Acacia Research

  • Thursday's Range: $3.41-$3.90
  • 52-Week Range: $3.30-$13.50
  • Thursday's Volume: 444,000
  • Three-Month Average Volume: 774,821

Acacia Research  (ACTG - Get Report) , through its subsidiaries, invests in, develops, licenses and enforces patented technologies in the U.S. This stock is trading up 7.8% to $3.80 in Thursday's trading session.

From a technical perspective, Acacia Research is ripping sharply higher here back above its 20-day moving average of $3.68 a share with decent upside volume flows. This stock recently attempted to form a double bottom chart pattern, after shares found some buying interest at $3.30 to $3.41 a share. Following that potential bottom, this stock has started to rip higher with decent volume, and it's now quickly moving within range of triggering a near-term breakout trade. That trade will trigger if shares of Acacia Research manages to take out some near-term overhead resistance levels at $3.90 to $3.97 a share and then once it clears more key resistance levels $4 to $4.24 a share with high volume.

Traders should now look for long-biased trades in Acacia Research as long as it's trending above those double bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 774,821 shares. If that breakout gets set off soon, then this stock will set up to re-test or possibly take out is next major overhead resistance levels at $4.49 to its 50-day moving average of $4.57, or even $5 to $5.50 a share.

Navistar International

  • Thursday's Range: $6.93-$7.80
  • 52-Week Range: $5.78-$31.28
  • Thursday's Volume: 940,000
  • Three-Month Average Volume: 1.86 million

Navistar International  (NAV - Get Report)  manufactures and sells commercial and military trucks, diesel engines and school and commercial buses; and provides service parts for trucks and diesel engines worldwide. This stock is trading up 9% to $7.57 in Thursday's trading session.

From a technical perspective, Navistar International is ripping sharply higher here right off its 20-day moving average of $7.03 a share with decent upside volume flows. This spike to the upside has now pushed this stock into breakout territory, since shares of Navistar International have started to take out some near-term overhead resistance at $7.37 a share. This move is now quickly pushing this stock within range of triggering a much bigger breakout trade above some key near-term overhead resistance levels. That trade will trigger if shares of Navistar International manages to take out some key near-term overhead resistance levels at $7.80 to $8 a share with high volume.

Traders should now look for long-biased trades in Navistar International as long as it's trending above Thursday's intraday low of $6.93 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.86 million shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8.50 to $9, or even its 50-day moving average of $9.14 to $9.60 a share.

Advaxis

  • Thursday's Range: $6.40-$7.24
  • 52-Week Range: $6.15-$30.13
  • Thursday's Volume: 519,000
  • Three-Month Average Volume: 936,311

Advaxis  (ADXS - Get Report) , a clinical stage biotechnology company, focuses on the discovery, development and commercialization of Lm-LLO cancer immunotherapies in the U.S. This stock is trading up 5.2% to $6.85 in Thursday's trading session.

From a technical perspective, Advaxis is spiking sharply higher here right above its new 52-week low of $6.15 a share with decent upside volume flows. This stock has been attempting to carve out a double bottom chart pattern over the last few weeks, with shares finding some buying interest at $6.28 to $6.15 a share. Shares of Advaxis are now starting to rip to the upside off those support levels, and it's beginning to move within range of triggering a big breakout trade above some key near-term overhead resistance levels. That trade will hit if shares of Advaxis manages to take out its 20-day moving average of $7.19 a share and then once it clears more key resistance levels at $7.81 to $8 a share with high volume.

Traders should now look for long-biased trades in Advaxis as long as it's trending above its new 52-week low of $6.15 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 936,311 shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8.70 to its 50-day moving average of $9.53 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.